Introduction
Vascular tone develops through the regulated contraction and relaxation of vascular smooth muscle cells (VSMCs). Factors that regulate vasodilation include nitric oxide (NO), endotheliumderived hyperpolarizing factor (epoxyeicosatrienoic acid) and prostacyclin, while thromboxane A2, endothelin 1, angiotensin II and reactive oxygen species (ROS) regulate vasoconstriction [1]. Injury by ROS may adversely affect endothelial function in part through inhibition of NO synthesis in endothelial cells [2], an effect observed as augmented vasoconstriction.
ROS form in the course of metabolic processes involving oxygen, as in mitochondrial oxidative phosphorylation, in which glucose is oxidized to form water, carbon dioxide and high-energy metabolites (ATP, NADPH). Cells of the immune system generate ROS in the destruction of pathogenic cells and microorganisms, and liver cytochrome systems activate molecular oxygen in the biotransformation of drugs, nutrients, hormones and xenobiotic compounds. Platelet aggregation and wound healing involve free-radical biochemistry. ROS may also form spontaneously, given the ubiquitous presence of molecular oxygen, reducing agents and transition metals such as iron and copper in living systems, and through radiation exposure. The intermediate forms of oxygen activation, including superoxide radical (O2-), hydrogen peroxide (H2O2) and hydroxyl radical (OH•), may also induce tissue injury (oxidative stress) [3].
Within the circulatory system, ROS within the physiologic range of concentrations serve to regulate VSMC contraction and relaxation [4]. At increasing concentrations, however, ROS may contribute to the pathological effects of ischemia-reperfusion, inflammation, hypertension, diabetes mellitus and atherosclerosis, through oxidative injury to blood vessels [5,6].
Cell injury mediated by ischemia-reperfusion or inflammation may be reduced by the antioxidant effects of intravascular or inhalation anesthetics [7]. Local anesthetics such as lidocaine also display antioxidant activity [8]. However, the potential antioxidant effects of muscle relaxants on vascular endothelium have received little attention as compared to the direct relaxation effects of these drugs on VSMCs through induction of prostaglandin synthesis [9,10].
To investigate the antioxidant activities of muscle relaxants, we tested the effects of vecuronium and rocuronium on the impairment of acetylcholine (ACh)-induced relaxation in rabbit aorta following exposure to ROS, and we probed the mechanism of these effects.
Materials and Methods
Preparation of aortic ring segments and recording
The regulatory committee for the use of animals in research Laboratory Animal Committee at Hanyang University approved this study. Twenty-seven male New Zealand White rabbits, 2.0-2.5 kg, (KOATECH, Pyeongtaek, Korea) were anesthetized with 3-5 vol% sevoflurane in 4 L/min of 100% oxygen. Heparin 600 IU/kg was administered through auricular marginal vein. After 10 minutes, we exsanguinated the rabbits by cutting the carotid artery.
The abdominal aorta was carefully excised and placed on a petri dish containing Krebs-Henseleit solution (K-H solution) containing [in mM]: NaCl 120.0, NaHCO3 25.0, KCl 5.0, MgSO4 1.2, CaCl2 2.5, NaH2PO4 1.4, and glucose 11.0 at 4℃. Fat and surrounding connective tissue were trimmed away from the aorta without injury to vascular smooth muscle and endothelial cells, and the aorta was sectioned into rings of 2 to 3 mm in length.
Each aortic ring segment was placed between two L-shaped stainless steel hooks in an organ bath containing 5 ml K-H solution and maintained at 37 ± 0.5℃. The organ bath was continuously supplied with a mixture of 95% oxygen and 5% carbon dioxide. The lower hook was fixed to the organ bath and the upper one to a force displacement transducer (TSD125C; BIOPAC Systems Inc., Goleta, CA, USA). Isometric tension of vascular smooth muscle was continuously recorded on a personal computer by a data acquisition system (MP100 system, BIOPAC Systems Inc., Goleta, CA, USA) by means of a transducer amplifier (DA100C, BIOPAC Systems Inc., USA). The aortic ring segments were equilibrated with the organ bath system for 90 minutes. During this period, the K-H solution was exchanged every 15 minutes and resting tension was maintained at 2 g.
Assessment of endothelial integrity in abdominal aortic ring segments
After equilibration, the status of endothelial tissue in the aortic ring segment was determined as the percent tension reduction induced by serial administration of ACh at 3 × 10-8, 10-7, 3 × 10-7 and 10-6 M following precontraction induced by norepinephrine (NE) at 10-6 M [11,12]. The aortic ring segments showing relaxation greater than 70% were considered to be intact, and were used for these experiments [13].
Exposure of aortic ring segments to ROS
Reactive oxygen species were generated by electrolysis in the solution bathing the aortic ring segments. Two circular platinum wire electrodes (7.5 mm) were placed near the bottom of the organ bath, and a constant current of 15 mA was applied for 35 seconds. A space separation of 1 cm between electrode and the aortic ring segments effectively prevented direct electrical stimulation.
Control group experiment
After confirming preservation of vascular endothelium and allowing the system to equilibrate for 15 minutes, we generated ROS by electrolysis and replaced the K-H solution. Using NE (10-6 M) and ACh (3 × 10-8, 10-7, 3 × 10-7, 10-6 M), as described above, the aortic ring segments were then contracted and relaxed. The percent tension reduction induced by ACh following precontraction with NE was adopted as the control value.
Effect of ROS on endothelial response following vecuronium or rocuronium pretreatment
After confirming preservation of vascular endothelium and allowing 15 minutes for equilibration, vecuronium or rocuronium was introduced into the organ bath at concentrations of 10-4, 3 × 10-4, 10-3 or 3 × 10-3 M. After 15 min, we generated ROS by electrolysis and changed the K-H solution. The aortic ring segments were contracted and relaxed (see above), and the percent relaxation was calculated as the experimental value.
Effect of ROS on endothelial response following antioxidant enzyme inhibition
Endogenous antioxidant capacity in the isolated aortic ring segments was reduced using diethyldithiocarbamate (DETCA) as an inhibitor of Cu/Zn superoxide dismutase (SOD) and 3-amino-1,2,4-triazole (3AT) as catalase inhibitor. After confirming endothelial integrity in aortic ring segments and allowing 15 minutes for equilibration, DETCA (0.8 mM) or 3AT (50 mM) was introduced into the organ bath for 30 minutes. Either vecuronium (3 × 10-3 M) or rocuronium (3 × 10-3 M) was then added for 15 minutes and electrolysis was initiated and the K-H solution was changed. The aortic ring segments were contracted and relaxed as described above, and the percent relaxation was calculated as the experimental value.
Concentrations of DETCA reported in various studies range from 0.1 mM to 1.0 mM. We used DETCA at 0.8 mM, because this produced significant inhibition of the ACh-induced relaxation.
Drugs
The NE, ACh, DETCA and 3AT used in these experiments were purchased from Sigma Chemical Company, St Louis, MO, USA, and vecuronium and rocuronium were purchased from N.V. Organon, Oss, The Netherlands. All of these drugs were dissolved in deionized water on the day of the experiment, and portions not used were kept frozen at -20℃.
Statistical analysis
Statistical calculations were performed using PASW 18.0 (SPSS Inc., Chicago, IL, USA). We used one-way ANOVA for the effects of vecuronium and rocuronium on ACh-induced relaxation following ROS-induced vascular injury, and Dunnett's test was performed as post-hoc. An unpaired t-test was used to compare the percent vascular relaxation between groups pretreated with DETCA or 3AT and a non-pretreated group. All data were presented as the mean ± error deviation, and a P value less than 0.05 was considered to be statistically significant.
Results
From 27 rabbits, we obtained 8 abdominal aortic ring segments per rabbit, after excluding 20 segments that did not relax more than 70%. Twelve experimental groups, with 15 aortic ring segments per group, were assigned including 8 groups corresponding to the concentrations of vecuronium or rocuronium (10-4, 3 × 10-4, 10-3, 3 × 10-3 M) and 2 groups each for the DETCA and 3AT pretreatments (Fig. 1).
The control group consisted of 15 ring segments, not exposed to any pretreatment, in which we measured the percent relaxation after exposure to ROS. The control value (n = 15) was -0.38 ± 2.0%.
Effects of muscle relaxant pretreatment on vascular endothelium after ROS-induced injury
Following exposure to ROS generated in the organ bath, aortic ring segments did not display the relaxation response to ACh 10-6 M. In contrast, groups of aortic rings pretreated with vecuronium (10-4, 3 × 10-4, 10-3, 3 × 10-3 M) showed a dose-dependent preservation of the ACh-induced relaxation response (Fig. 2). Groups pretreated with vecuronium 3 × 10-4, 10-3 and 3 × 10-3 M differed significantly from control groups in the ACh-induced relaxation response following ROS exposure (P < 0.001) (Fig. 2). Rocuronium pretreatment at 3 × 10-4, 10-3 and 3 × 10-3 M produced a response similar to that of vecuronium (P < 0.001) (Fig. 3).
Effect of antioxidant enzyme inhibition on protection from ROS-induced endothelial injury
Following exposure to ROS, aortic rings pretreated with DETCA + vecuronium (3 × 10-3 M) showed a reduction in the extent of ACh-induced relaxation as compared to the group pretreated with vecuronium (3 × 10-3 M) only (66.0 ± 3.7% compared with 85.4 ± 1.9%; P < 0.001) (Fig. 4). However, the groups pretreated with vecuronium (3 × 10-3 M) + 3AT and vecuronium (3 × 10-3 M) only did not differ significantly. The relaxation response in aortic rings pretreated with DETCA + rocuronium 3 × 10-3 M (72.4 ± 2.5%) was also reduced as compared with rocuronium 3 × 10-3 M only (85.5 ± 1.8%) (P < 0.001) (Fig. 5). However, the groups pretreated with 3AT + rocuronium (3 × 10-3 M) and rocuronium (3 × 10-3 M) only did not differ in the ACh-induced relaxation response following ROS exposure (86.9 ± 1.7%).
Discussion
Through experiments with rabbit abdominal aortic ring segments, we knew that the muscle relaxants rocuronium and vecuronium attenuated the ROS-induced impairment of ACh-induced relaxation of the vascular endothelium. Based on these observations, we hypothesized that the muscle relaxants exert antioxidant effects. In the present study, the superoxide dismutase inhibitor DETCA inhibited the protective effect of vecuronium and rocuronium on the ACh-induced relaxation response following ROS exposure, while the catalase inhibitor 3-AT had no effect.
The non-depolarizing muscle relaxants include primarily the aminosteroid and benzylisoquinolinium compounds. These drugs act as antagonists at the nicotinic ACh receptor of the neuromuscular junction through competitive interaction with ACh; however, they exert no effects on VSMCs [14]. Vecuronium and rocuronium are aminosteroids.
Previous studies demonstrate the effects of muscle relaxants on vascular smooth muscle using the aortic ring segment model [9,10,15]; however, those studies concern the direct effects of the drugs on vascular smooth muscle contraction and relaxation, and describe effects in the coronary artery of the dog [15] and pig [10], and thoracic aorta of the rat [9]. In those studies, the vascular effects of the muscle relaxants varied according to the type and concentration of drug. The relaxation effects of the drugs in vascular smooth muscle increased in the following order: pancuronium < rocuronium < vecuronium [9]. As the relaxation effects in vascular smooth muscle did not depend on the status of the vascular endothelium, any effect of the drug on vascular endothelium will not be related to its potency in vascular smooth muscle relaxation [9,10,15].
The present study was conducted not to confirm direct effects of muscle relaxants on vascular smooth muscle, but to investigate the effects of the drugs on the vascular endothelial function following ROS-induced injury. The ACh-induced relaxation of vascular smooth muscle occurs through guanylyl cyclase activation and NO generation in vascular endothelium [16]. Following ROS-induced injury to vascular endothelium, the dose-dependent preservation of ACh-induced relaxation by vecuronium or rocuronium implies that the muscle relaxants act as ROS scavengers in this setting.
Reactive oxygen species perform vital regulatory functions as second messengers in cell growth, proliferation, endothelial barrier function, vasorelaxation, and vascular remodeling [17]. These species arise not only in vascular endothelium, but also in vascular media or adventitia. ROS may participate in the induction of an endothelium-dependent or independent vascular relaxation effect through modulation of NO signaling [18]. Physiologically, the superoxide radical (O2•-) and H2O2 play prominent roles [3]. Important ROS include O2•-, OH•, peroxyl (ROO•), hydroperoxyl (HO2•) radicals and non-radical oxidizing agents that readily convert to H2O2, hypochlorous acid or ozone [19]. Superoxide dismutase converts the superoxide anion to hydrogen peroxide, which is reduced to H2O and oxygen by catalase or glutathione peroxidase. Hydrogen peroxide or superoxide anion may also arise through the Fenton reaction (Fe2+ + H2O2 → Fe3+ + OH• + OH-) reacting with metal like copper or Haber-Weiss reaction (O2•- + H2O2 → OH• + OH- + O2) [1]. In biological systems, a reducing compound such as ascorbate, in conjunction with the Fenton reaction, may catalyze a cycle of destructive interaction with tissue components. Oxygen activation at the time of ischemia-reperfusion induces vascular endothelial injury [20], with significant clinical effects in the heart, brain and blood vessels [21-23].
In the present study, the SOD inhibitor DETCA appeared to antagonize the protective effect of vecuronium and rocuronium on ROS-induced injury to aortic ring segments. An inhibitor of catalase, 3A, did not show similar effect. These results imply that vecuronium and rocuronium may exert antioxidant effects through superoxide-anion scavenging.
ACh-induced relaxation may represent not only the action of NO, but also or alternatively an increase in intracellular Ca2+ induced by cyclic guanosine monophosphate [24] or the inhibition of nicotinamide adenine dinucelotide phosphate oxidase [25]. These pathways present mechanisms by which the non-depolarizing muscle relaxant might influence ACh-induced relaxation in addition or alternative to superoxide anion scavenging.
Electrolysis in physiologic salt solution has been previously shown to generate ROS, including O2•-., H2O2, OH• radicals [26]. The K-H solution used in the physiologic salt solution may contain ascorbic acid (1.1 × 10-4 M), which may act either as an antioxidant or as potentiator of the Fenton reaction, depending on ambient conditions [27]. Hence, we did not add ascorbic acid to the K-H solution.
Following the electrolysis, the K-H solution was exchanged thereby removing ROS; thus the inhibition of Ach-induced vascular relaxation must have occurred through modification of the vascular endothelium, rather than by NO inactivation.
In a clinical setting, the doses of muscle relaxants administered are unlikely to exert antioxidant effects. Peak rocuronium concentration just after intravenous administration is 7 µg/ml [28], and a plasma vecuronium concentration of 0.1 µg/ml induces 50% neuromuscular blockade [29]. The corresponding plasma concentrations of vecuronium and rocuronium at these times are 1.6 × 10-7 and 1.1 × 10-5 M, respectively. The lowest concentration we used for these drugs in the present experiments was 10-4 M. At this drug concentration, the degree of ACh-induced relaxation following exposure to ROS was 2.8 ± 1.9% for pretreatment with vecuronium and 4.8 ± 1.1% for rocuronium. These values represent very weak antioxidant activity in either case.
Although we did not directly quantify the ROS generated by electrolysis, we feel that our results clearly demonstrate the antioxidant effects of these muscle relaxants. Similarly, although the muscle relaxant appears to act as a superoxide radical scavenger, we did not quantify the dose-response relationship between ROS and either drug. The rocuronium was dissolved a solution containing sodium acetate trihydrate, sodium chloride and glacial acetic acid, which may potentially have influenced our findings; however, we did not perform a solvent control.
As our principal finding, we report that the aminosteroid muscle relaxants vecuronium and rocuronium dose-dependently preserved the capacity for ACh-induced relaxation in rabbit abdominal aortic ring segments exposed to ROS. In this protective effect, the drugs may perform as superoxide anion scavengers.
PDF Links
PubReader
XML Download
Full text via DOI
Full text via PMC
Download Citation
Print
